Hvis inhibitoren er tilstede i niveauer mindre end 10 Bethesda Enheder (BE) pr. ml, kan indgift af yderligere KOGENATE Bayer eventuelt neutralisere inhibitoren og tillade fortsat klinisk effektiv behandling med KOGENATE Bayer.
If the inhibitor is present at levels less than 10 Bethesda Units (BU) per ml, administration of additional recombinant coagulation factor VIII may neutralise the inhibitor and permit continued clinically effective therapy with KOGENATE Bayer.